Tandem Investment Advisors Inc. lifted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 12,042.9% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 308,672 shares of the company’s stock after acquiring an additional 306,130 shares during the quarter. Procter & Gamble accounts for about 2.2% of Tandem Investment Advisors Inc.’s investment portfolio, making the stock its 22nd largest holding. Tandem Investment Advisors Inc.’s holdings in Procter & Gamble were worth $44,585,000 at the end of the most recent quarter.
A number of other hedge funds have also bought and sold shares of the business. Carson Advisory Inc. lifted its position in shares of Procter & Gamble by 0.5% during the fourth quarter. Carson Advisory Inc. now owns 12,124 shares of the company’s stock worth $1,738,000 after acquiring an additional 65 shares in the last quarter. Trilogy Capital Inc. grew its position in shares of Procter & Gamble by 1.1% in the fourth quarter. Trilogy Capital Inc. now owns 6,289 shares of the company’s stock valued at $901,000 after purchasing an additional 67 shares in the last quarter. Cary Street Partners Investment Advisory LLC grew its position in shares of Procter & Gamble by 1.8% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company’s stock valued at $549,000 after purchasing an additional 67 shares in the last quarter. Lorne Steinberg Wealth Management Inc. raised its stake in shares of Procter & Gamble by 2.7% during the 4th quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company’s stock valued at $376,000 after purchasing an additional 68 shares during the period. Finally, Grant Street Asset Management Inc. lifted its holdings in Procter & Gamble by 2.7% during the 4th quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company’s stock worth $376,000 after purchasing an additional 69 shares in the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
NYSE:PG opened at $149.84 on Friday. The firm has a market capitalization of $348.92 billion, a price-to-earnings ratio of 21.91, a P/E/G ratio of 7.31 and a beta of 0.39. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $167.25. The stock has a fifty day moving average of $146.80 and a 200 day moving average of $148.54. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Investors of record on Friday, July 24th will be given a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Friday, July 24th. Procter & Gamble’s dividend payout ratio is 63.60%.
Wall Street Analysts Forecast Growth
Several research analysts have commented on PG shares. Rothschild & Co Redburn cut their target price on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research note on Monday, April 27th. UBS Group upped their price target on Procter & Gamble from $166.00 to $172.00 and gave the company a “buy” rating in a research report on Monday, April 27th. Morgan Stanley lowered their price target on shares of Procter & Gamble from $175.00 to $166.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. The Goldman Sachs Group cut their price objective on shares of Procter & Gamble from $159.00 to $155.00 and set a “neutral” rating for the company in a research report on Wednesday, April 8th. Finally, Erste Group Bank cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Tuesday, March 24th. Twelve equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and an average target price of $161.42.
View Our Latest Analysis on Procter & Gamble
Procter & Gamble News Roundup
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Procter & Gamble’s long dividend track record remains a key support for the stock, with the company having raised its payout for 70 consecutive years, reinforcing its status as a dependable income name. Article title
- Positive Sentiment: JPMorgan kept an overweight rating on PG while only trimming its price target to $162 from $164, signaling continued upside expectations from current levels. Article title
- Positive Sentiment: Some commentary says PG still screens as undervalued and could benefit from planned cuts to as many as 7,000 non-manufacturing roles, which may improve margins over time. Article title
- Neutral Sentiment: Erste Group slightly lowered its FY2026 and FY2027 earnings estimates, but the changes were minimal and its full-year FY2026 forecast still matches consensus. Article title
- Neutral Sentiment: UBS said consumer-staple companies likely had another “tricky” quarter, which suggests a challenging operating backdrop for PG and peers rather than a company-specific setback. Article title
- Negative Sentiment: The stock is also being pressured by a broader risk-off move and weakness in equities, including a selloff in growth/AI-related names that has pushed some investors back toward defensive stocks like PG. Article title
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
